Acute exposure to environmental tobacco smoke reduces HDL-C and HDL 2-C

Preventive Medicine

Volumn 38, Issue 5, 2004, Pages 637-641

  Moffatt, Robert J ^a   Chelland, Sara A ^a   Pecott, Deborah L ^a   Stamford, Bryant A ^b  

^a FLORIDA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Environmental tobacco smoke; HDL C; Lipoproteins; Nicotine

Indexed keywords

HIGH DENSITY LIPOPROTEIN 2 CHOLESTEROL; HIGH DENSITY LIPOPROTEIN 3 CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PASSIVE SMOKING; PRIORITY JOURNAL; TIME; VEIN;

ADULT; CARBON MONOXIDE; CHOLESTEROL, HDL; ENVIRONMENTAL EXPOSURE; FLORIDA; HUMANS; MALE; NICOTINE; TOBACCO SMOKE POLLUTION;

EID: 1842423304     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2003.12.002     Document Type: Article

References (41)

1. Garland C., Barrett-Connor E., Suarez L., Criqui M.H., Wingard D.L. Effects of passive smoking on ischemic heart disease mortality of nonsmokers. Am. J. Epidemiol. 121:1985;645-650.
2. He Y., Lam T.H., Li L.S., Li L.S., Du R.Y., Jia G.L.et al. Passive smoking a work as a risk factor for coronary heart disease in Chinese women who have never smoked. Br. Med. J. 308:1994;380-384.
3. Helsing K.J., Sandler D.P., Comstock G.W., Chee E. Heart disease mortality in nonsmokers living with smokers. Am. J. Epidemiol. 127:1988;915-922.
4. Hole D.J., Gillis C.R., Chopra C., Hawthorne V.M. Passive smoking and cardiorespiratory health in a general population in the west of Scotland. Br. Med. J. 299:1989;423-427.
5. Humble C., Croft J., Gerber A., Casper M., Hames C.G., Tyroler H.A. Passive smoking and 20-year cardiovascular mortality among nonsmoking wives, Evans County Georgia. Am. J. Public Health. 80:1990;599-601.
6. Svedson K.H., Kuller L.H., Martin M.J., Ockene J.K. Effects of passive smoking in the multiple risk factor intervention trial. Am. J. Epidemiol. 126:1987;783-795.
7. Glantz S.A., Parmley W.W. Passive smoking and heart disease: epidemiology, physiology, and biochemistry. Circulation. 83:1991;1-12.
8. Forde O.H., Thelle D.S., Arnessen E., Mjos O.D. Distribution of high density lipoprotein cholesterol according to relative body weight, cigarette smoking and leisure time physical activity. Acta Med. Scand. 219:1986;167-171.
9. Freeman D.J., Griffin B.A., Murray E., Lindsay G.M., Gaffney D., Packard C.J.et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfractions distributions. Eur. J. Clin. Investig. 23:1993;630-640.
10. Haffner S.M., Apple-baum-Bowden D., Whal P.W., Hoover J.J., Warnick G.R., Albers J.J.et al. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyl-transferase: effects of smoking, alcohol and adiposity. Arteriosclerosis. 5:1985;169-177.
11. Kannel W.B. Update on the role of cigarette smoking in coronary artery disease. Curric. Cardiol. 101:1980;319-328.
12. Njolstad I., Arnesen E., Lund-Larson P.G. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. Circulation. 93:1996;450-456.
13. Shennan N.M., Seed M., Wynn V. Variation in serum lipid and lipoprotein levels associated with changes in smoking behavior in non-obese Caucasian males. Atherosclerosis. 58:1985;17-25.
14. Whig J., Singh C.B., Soni G.L., Bansal A.K. Serum lipids and lipoprotein profiles of cigarettes smokers and passive smokers. Indian J. Med. Res. [B] 96:1992;282-287.
15. Hirayama T. Passive smoking. N. Z. Med. J. 54:1990;i.
16. Sandler D.P., Comstock G.W., Helsing K.J., Shore D.L. Deaths from all causes in nonsmokers who lived with smokers. Am. J. Public Health. 79:1989;163-167.
17. He Y. Women's passive smoking and coronary heart disease. Chin. J. Prev. Med. 23:1989;19-22.
18. Steenland K., Thun M., Lally C., Heath C. Jr. Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation. 94:1996;622-628.
19. Moffatt R.J., Stamford B.A., Biggerstaff K.D. Influence of environmental tobacco smoke on serum lipoprotein profiles of female nonsmokers. Metabolism. 44:1995;1536-1539.
20. Kantor M.A., Cullinane E.M., Sady S.P., Herbert P.N., Thompson P.D. Exercise acutely increases high-density lipoprotein-cholesterol and lipoprotein lipase activity in trained and untrained men. Metabolism. 36(2):1987;188-192.
21. Swank A.M., Robertson R.J., Dietrich R.W., Bates M. The effect of acute exercise on high density lipoprotein cholesterol and the subfractions in females. Atherosclerosis. 63:1987;187-192.
22. Wallace M.B., Moffatt R.J., Haymes E.M., Green N.R. Acute effects of resistance exercise on parameters of lipid metabolism. Med. Sci. Sports Exer. 23(2):1991;199-204.
23. Siegal M. Involuntary smoking in the restaurant workplace: a review of employee exposure and health effects. JAMA. 270:1993;490-493.
24. Allain C.C., Poon L.S., Chan C., Richmond W., Fu P.C. Enzymatic determinations of total serum cholesterol. Clin. Chem. 20:1974;470-476.
25. Gidez L., Miller G., Burstein M., Slagle S., Eder H.A. Separation and quantification of subclasses of human plasma high density lipoproteins by simple precipitation procedure. J. Lipid Res. 23:1982;1206-1223.
26. ++ precipitation. Clin. Chem. 28(7):1982;1574.
27. Cohen J. Statistical Power Analysis for the Behavior Sciences. 1977;Academic Press, New York, NY.
28. Neufeld E.J., Mietus-Snyder M., Beiser A.S., Baker A.L., Newburger J.W. Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profiles. Circulation. 96(5):1997;1403-1407.
29. Feldman J., Shenker R., Etzel R.A., Spierto F.W., Lilienfeld D.E., Nussbaum M.et al. Passive smoking alters lipid profiles in adolescents. Pediatrics. 88:1991;259-264.
30. Kawachi I., Pierce N., Jackson R.T. Deaths from lung cancer and ischemic heart disease due to passive smoking in New Zealand. N. Z. Med. J. 102:1989;337-340.
31. Benowitz N.L., Gourlay S.G. Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. J. Am. Coll. Cardiol. 29:1997;1422-1431.
32. Henningfield J.E., Stapleton J.M., Benowitz N.L., Grayson R.F., London E.D. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend. 33:1993;23-29.
33. Besaratinia A., Mass L.M., Brouwer E.M.C., Moonen E.J.C., De Kok T.M.C.M., Wesseling G.J.et al. A molecular dosimetry approach to assess human exposure to environmental tobacco smoke. Carcinogenesis. 23(7):2002;1171-1176.
34. Moriguchi E.H., Fusegawa Y., Tamachi H., Goto Y. Effects of smoking on HDL subfractions in myocardial infarction patients: effects on LCAT and hepatic lipase. Clin. Chim. Acta. 195:1990;139-144.
35. McCall M.R., van den Berg J.J.M., Kuypers F.A., Tribble D.L., Krauss R.M., Knoff L.J.et al. Modification of LCAT activity and HDL structure: new links between cigarette smoke and coronary heart disease. Arterioscler. Thromb. 14:1994;248-253.
36. Bielicki J.K., Forte T.M., McCall M.R. Gas-phase cigarette smoke inhibits plasma lecithin cholesterol acyl-transferase activity by modification of the enzyme's free thiols. Biochem. Biophys. Acta. 1258:1995;35-40.
37. Freeman D.J., Caslake M.J., Griffin B.A., Hinnie J., Tan C.E., Watson T.D.et al. The effect of smoking on post-heparin LPL, hepatic lipase, CETP and LCAT activities in human plasma. Eur. J. Clin. Investig. 28:1998;584-591.
38. Mero N., Van Tol A., Scheek L.M., Van Gent T., Labeur C., Rosseneu M.et al. Decreased post prandial HDL-C and Apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activity. J. Lipid Res. 39:1998;493-502.
39. Astrup P., Kjeldson K., Wanstrup J. Enhancing influence of carbon monoxide on the development of atheromatosis in cholesterol-fed rabbits. J. Atherscler. Res. 7:1967;343-354.
40. Dwyer E.M. Jr., Turino G.M. Carbon monoxide and cardiovascular disease. N. Engl. J. Med. 321(21):1989;1474-1475.
41. Allred E.N., Bleecker E.R., Chaitman B.R., Dahms T.E., Gottlieb S.O., Hackney J.D.et al. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N. Engl. J. Med. 321:1989;1426-1432.